sector medic suppli devic
messag deliv solid perform revenu top consensu
ep yoy beat penni organ sale growth came
adjust sell day strong show ortho busi
off-set mix medsurg perform disappoint quarter spine back
result manag expect full year organ revenu growth
high end prior guidanc rang see achiev given
compani current momentum level like sustain well
maintain price target reiter buy rate
diversifi portfolio busi continu deliv top tier growth
third quarter revenu ahead consensu rose
underli basi adjust extra sell day mark compani thirteenth
straight quarter top line gain overal sale result solid individu
compon littl mix ortho post revenu organ top
consensu hand medsurg sale organ came
shi consensu neurotech spine miss medic
notabl standout quarter individu busi segment perspect
ortho exhibit strength across board knee hip trauma
extrem contribut upsid elsewher instrument
spine endoscopi fell shi consensu top
line ep came penni ahead street expect ebita
margin expand despit dilut recent
even robot competit begin heat mako continu demonstr strong
momentum place system yoy ahead estim
overal robot procedur volum mako tka case
flat sequenti still solidli yoy estim
 knee case perform robot year ago see
figur notabl compani announc sold system japan
open train facil hong kong manag highlight signific
untap opportun market meanwhil note mako adopt hip
procedur yoy see encourag sign compani
broader hip busi sustain mako growth trajectori
ortho busi display broad-bas strength total orthoped sale
rose cc beat consensu knee sale cc
top consensu elsewher trauma extrem sale cc
beat aid roll-out alpha nail system double-digit growth
foot ankl shoulder hip revenu cc also beat see
hip perform particularli encourag mark third straight quarter
cc growth busi back aforement mako tailwind grow
adopt trident ii acetabular cup
meanwhil medic bright spot mix quarter medsurg
report medsurg sale organ consensu medic
revenu organ top consensu meanwhil instrument
revenu organ came street expect
deceler sharpli gain previou two quarter manag attribut
weak tough yoy comp well sale forc
restructur result backlog head elsewher endoscopi sale
organ miss consensu camera launch still
build momentum expect endoscopi growth improv move final
sustain divis post revenu ahead street continu
page
page analyst certif import disclosur
compani report guggenheim secur llc estim
compani report guggenheim secur llc estim
elsewher neurotech spine underwhelm total neurotech spine
sale grew organ basi short consensu spine sale
miss street expect pro forma basi
integr still on-going manag indic salesforc
integr process isnt progress quickli expect due cross-sel scale
rep hire full inventori avail take longer origin plan result
manag expect combin busi deliv low-single-digit pro forma
growth overal vs prior mid-single-digit target manag express
confid busi acceler see worrisom data point
given long histori challeng integr spine deal posit note
cost synergi relat integr track ahead schedul meanwhil
estim neuro organ growth essenti flat sequenti solid organ
revenu miss consensu forecast
top line solid opex control allow revenu beat flow
ep stryker gross margin contract yoy came
consensu neg impact price pressur busi mix sg
spend increas yoy sale consensu meanwhil
spend grew yoy sale lower street model
collect result ebita margin yoy
adjust estim model call post ep
sale organ compar previou estim
respect long-term believ right mix end
market differenti product expertis sustain top line growth
next year combin improv execut margin
set compani one best fundament stori large-cap med-tech
view share trade modest premium broader large-cap med-tech
group today ntm ep vs believ compani fundament outlook
support premium valuat maintain price target
base multipl revis forward ntm ep estim signific
upsid potenti target current level reiter buy rate
page analyst certif import disclosur
believ diversifi busi model posit sustain revenu growth
high end large-cap group compani seven differ busi
contribut overal revenu one franchis respons
uniqu model insul temporari weak one
segment view allow cast wide net potenti valu creat
acquisit result one consist top line growth stori large-
cap med-tech past year expect continu go forward drive
sustain ep growth potenti faster gain execut around
margin leverag improv deploy balanc sheet capac net
debt/ebitda today product manner believ profil warrant premium
valuat rel peer
share current trade ntm ep estim ntm
ebitda premium large-cap med-tech averag ntm ep
ntm ebitda believ superior growth profil peg
top bottom line vs group averag warrant
premium valuat maintain price target base
multipl revis forward ntm ep estim signific upsid potenti
target current level assign stryker buy rate
downsid risk rate price target includ slowdown mako adopt
competit robot surgeri system roll increas price and/or volum pressur
ortho implant manufactur govern initi contain healthcar cost
weak hospit capit equip spend could neg impact
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
